Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

(-)-17-(cyclopropylmethyl)-3,14 ß-dihydroxy-4,5 α-epoxy-6ß-[N-methyl-trans-3-(3-furyl) acrylamido] morphinan hydrochloride (intravenous use)

EU orphan designation number: EU/3/02/115   
Active ingredient: (-)-17-(cyclopropylmethyl)-3,14 ß-dihydroxy-4,5 α-epoxy-6ß-[N-methyl-trans-3-(3-furyl) acrylamido] morphinan hydrochloride (intravenous use)
Indication: Treatment of uremic pruritus
Sponsor: Toray International U.K. Limited
Verulam Gardens, 70 Gray’s Inn Road, London, WC1X 8NH, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/09/2002 Orphan designation EMEA/OD/020/02 (2002)3404 of 11/09/2002
23/01/2008 Change of name and/or address of sponsor